PMID
int64 35.7M
36.4M
| Title/Abstract
stringlengths 22
8.78k
| MeshTerms
stringlengths 7
101
| SemanticTypes
stringlengths 4
64
|
|---|---|---|---|
36,314,621
|
chronic urticaria thorough histori physic examin vital accur diagnosi chronic urticaria extend laboratori test rare yield clinic signific action find henc recommend patient experi symptomat relief follow treatment h antihistamin omalizumab cyclosporin eventu spontan remiss
|
D000080223;D014581;D018926
|
T121;T047
|
36,314,616
|
examin util cysteamin treatment melasma current perspect melasma chronic cutan condit affect appear patient also immens psychosoci impact patient qualiti life although mani treatment option current avail singl univers treatment regimen work patient signific attent recent focus develop use topic treatment lighten dark patch associ melasma one ingredi receiv grow attent recent year cysteamin work sever mechan influenc melanogenesi pathway commentari review inform topic ingredi offer relev clinic insight skinm
|
D003543;D008548
|
T033;T121;T047;T109
|
36,314,615
|
pediatr hospit atop dermat unit state characterist associ atop triad atop dermat ad one common skin disord pediatr patient mani patient ad also asthma andor allerg rhiniti combin constitut atop triad studi character us pediatr patient hospit primari diagnosi ad eczema ad e determin characterist associ coexist addit diagnos triad retrospect analysi perform includ multivari logist regress model data nation inpati sampl patient met inclus criteria n consist predomin toddler male gender white race belong household lowest quartil annual incom cover medicaremedicaid mean length stay total charg signific higher patient ad e plus asthma andor allerg rhiniti compar patient ad e alon multivari analysi age sex signific associ presenc addit atop condit mid childhood group highest likelihood compar infant girl lower likelihood compar boy understand characterist associ addit atop condit children ad e well healthcar dispar popul may yield earli intervent enhanc care improv resourc alloc skinm
|
D003876;D001249;D065631
|
T047
|
36,314,614
|
anti pd agent treatment cutan squamous cell carcinoma cutan squamous cell carcinoma scc second common type skin cancer account approxim nonmelanoma skin cancer nmsc although major cutan scc lesion treat success surgic excis cryotherapi electrodess moh micrograph surgeri local advanc scc patient either inoper metastas patient treatment challeng due limit option review literatur describ mechan anti pd agent cancer therapi current pd blockad immunotherapi trial cutan scc current cemiplimab anti pd agent approv food drug administr treatment local advanc metastat scc review describ anti pd agent pembrolizumab nivolumab depict promis effect advanc scc result reduct tumor size minim advers effect immunotherapi target pd pd l axi must consid advanc cutan scc patient refractori first line procedur treatment option skinm
|
D002294;D012878
|
T191
|
36,314,613
|
monkeypox outbreak women children patient januari juli world health organ receiv report laboratori confirm patient monkeypox predomin men occur multi countri outbreak virus period women six children report infect monkeypox virus although infect number women children small data worrisom young children pregnant women increas risk sever outcom monkeypox one infant alreadi hospit intens care london england data regard monkeypox outbreak also indic healthcar worker diagnos monkeypox although still investig whether infect due occup exposur three death monkeypox report monkeypox outbreak special focus present monkeypox infect involv women children skinm
|
D045908;D016273
|
T047;T037
|
36,314,585
|
doubl papillari muscl reloc total endoscop robot assist approach detail techniqu total endoscop robot assist mitral valv repair reimplant ruptur papillari muscl head support doubl papillari muscl reloc mitral annuloplasti treatment nonacut ischem mitral regurgit
|
D065287;D058386;D008944
|
T061;T047
|
36,314,583
|
share resourc advanc translat research public resourc articl essenti dissemin novel substanti enhanc tool techniqu diseas model dataset resourc share knowledg resourc global access manner support human diseas research acceler translat fundament discoveri effect treatment diagnost divers patient popul promot encourag excel resourc articl diseas model mechan dmm launch new outstand resourc paper prize celebr highlight recent outstand dmm resourc articl ultim goal benefit human health
|
D057170;D001363
|
T062;T073
|
36,314,580
|
machin learn approach predict fluorin strength electrophil fluorin reagent unusu properti wide rang organofluorin compound provid strong incent scientif communiti develop field parallel constant grow number organofluorin compound unusu high number electrophil n f fluorin reagent emerg potenti fluorin achiev fluorin substitut simpl effici manner bench stabil crystallin natur modular synthesi key characterist make increas import synthet transform context import understand reactiv power n f fluorin reagent quantit manner experiment dft investig obtain quantit understand fluorin power reagent resourc intens labori expens herein propos machin learn approach predict relat power wide rang n f fluorin reagent util simpl fast smile base molecular encod approach neural network algorithm employ novel dataset consist four molecular descriptor two categor descriptor data point success predict fluorin plus detach valu n f fluorin reagent belong six differ categori
|
D054879;D005461
|
T123;T070;T067;T196;T068
|
36,314,577
|
character determin near road ambient air qualiti urban intersect freeway site near road ambient air pollut concentr affect vehicl emiss typic character substanti spatial variabl respect distanc roadway tempor variabl base time day day week season goal work identifi variabl explain either tempor spatial variabl base case studi freeway site urban intersect site key hypothesi dispers model near road pollut concentr could improv ad estim indic site specif explanatori variabl particular relat traffic base case studi freeway site urban intersect site specif aim project develop test regress model explain variabl traffic relat air pollut trap ambient concentr two near roadway locat develop test refin proxi land use traffic emiss dispers priorit input accord abil explain variabl ambient concentr help focus effort futur data collect model develop
|
D000397;D000393
|
T131;T069;T080
|
36,314,568
|
peopl behind paper roberto de gregorio ji sze serotonin uptak receptor sert play import role neural circuit develop reduc sert function associ neurodevelopment disord paper publish develop find sert act defin development time window hippocampus sex bias fashion absenc ca pyramid neuron lead defect neural circuit assembl electrophysiolog behaviour caught first author roberto de gregorio correspond author ji sze associ professor albert einstein colleg medicin find research
|
D006624;D017966
|
T026;T023;T025
|
36,314,552
|
test scale intervent improv tuberculosi infect care cascad tuberculosi tb prevent therapi tpt increas recogn key elimin tuberculosi global particular critic children tb infect close contact individu infecti tb mani barrier current imped success scale provid tpt high risk tb diseas cascad care tb infect relat contact manag cascad conceptu framework evalu improv care person potenti candid tpt review summar recent literatur barrier solut tb infect care cascad focus children high low burden set draw studi children adult identifi close gap care cascad requir implement tool new eg comput assist radiographi old eg effici contact trace aid innov implement studi design qualiti improv method share clinic practic primari care provid
|
D014376;D055985
|
T047
|
36,314,550
|
old new tuberculosi vaccin children tuberculosi tb lead caus global child mortal turn st centuri mycobacterium bovi bacill calmett guerin bcg vaccin prevent tb pediatr tb vaccin pipelin advanc past decad includ evalu novel whole cell vaccin replac infant bcg investig subunit whole cell vaccin boost tb immun adolesc describ histori bcg current tb vaccin candid clinic trial challeng opportun futur tb vaccin research children children critic target popul tb vaccin expans pediatr tb vaccin pipelin urgent need end tb pandem
|
D032581;D009163;D014376;D009169
|
T129;T047;T121;T007
|
36,314,549
|
social determin adher treatment tuberculosi infect diseas among children adolesc young adult narrat review global effort elimin tuberculosi tb must address uniqu barrier children age year adolescentsyoung adult aya age year face adher treatment tb infect diseas conduct narrat review summar current knowledg social determin treatment adher among age group guid effort polici address uniqu need find reveal research tb treatment adher among children aya still nascent stage current literatur reveal structuralcommun health system household individu level factor influenc treatment adher vari development stage need develop multilevel intervent address uniqu challeng children aya face adher tb treatment
|
D014376;D055985
|
T047
|
36,314,548
|
explor impact covid pandem tuberculosi care prevent covid pandem set back global tuberculosi tb respons sever year access tb prevent care declin sharpli tb notif drop compar declin pronounc children drop year old drop year old result number death due tb increas million across age revers decad long declin trend progress toward un high level meet target risk includ target relat children tb drug resist tb treatment tb prevent therapi nonetheless end tb envisag sustain develop goal sdgs still possibl requir increas invest acceler case detect subclin tb prevent therapi effect vaccin invest tb could prepar world better fight futur airborn pandem
|
D000086382;D014376;D018088
|
T047;T067
|
36,314,547
|
new drug regimen tuberculosi diseas treatment children adolesc almost year relat stagnat research past decad led remark advanc treatment drug suscept ds drug resist dr tuberculosi tb diseas children adolesc compar previous standard therapi least month new regimen last month treatment ds tb studi recommend world health organ along shorten month regimen treatment ds tb mening addit month regimen previous use dr tb includ pain inject drug high rate advers effect replac shorter safer oral regimen advanc improv treatment includ develop new tb drug bedaquilin delamanid pretomanid reapplic older tb drug rifampicin rifapentin repurpos drug clofazimin linezolid develop child friend formul mani drug enhanc abil safe effect treat ds dr tb children adolesc characterist use drug regimen formul review
|
D014376;D018088
|
T047
|
36,314,546
|
pediatr tuberculosi diagnost present futur current diagnost abil detect pediatr tuberculosi suboptim multipl factor contribut diagnosi intrathorac tuberculosi children name absenc pathognomon featur diseas low bacillari load respiratori specimen challeng sampl collect inadequ access diagnost tool high burden set nonetheless wit encourag progress area novel diagnost recent endors rapid molecular assay hold promis use servic decentr strategi new polici recommend includ stool altern child friend specimen test genexpert assay pipelin promis assay midlat stage develop expand novel pediatr candid biomark base host immun respons identifi use diagnost triag test new test meet pediatr target product profil priorit key peculiar need hard reach pediatr popul consid earli plan phase discoveri valid implement studi
|
D009169;D014376
|
T047;T007
|
36,314,545
|
tuberculosi children live hiv ongo progress challeng much recent progress control tuberculosi tb human immunodefici virus hiv epidem global howev advanc children lag behind tb hiv coinfect continu major driver pediatr mortal mani set review highlight recent research find area prevent diagnosi treatment hiv associ childhood tb key area futur research defin current prevent effort vaccin tb symptom screen tb prevent treatment demonstr benefici need optim children live hiv clhiv diagnosi hiv associ tb children remain major challeng depend heavili clinician abil judg array sign symptom imag find grow number promis diagnost tool improv accuraci feasibl treatment tb hiv coinfect also seen recent progress evid demonstr safeti effect shorter regimen treatment tb infect diseas improv understand interact antiretrovir tb medic howev sever evid gap drug drug interact persist especi young children drug resist tb acceler effort need area build upon current progress reduc burden tb clhiv
|
D014376;D015658;D060085
|
T047
|
36,314,542
|
induc displac ct increas diagnost accuraci asept loosen primari total hip arthroplasti induc displac ct compar cts acquir seri altern rotat femur provid visual quantit clue mechan situat ie loosen total hip arthroplasti report accuraci method well experi integr clinic workflow
|
D019644;D006622
|
T061;T074
|
36,314,540
|
pancrea organoid model develop regener organoid becom one fastest progress appli model biolog medic research various organoid develop organ bodi review method develop generat pancrea organoid vitro embryon fetal adult cell well pluripot stem cell discuss system use learn new aspect pancrea develop regener diseas well limit potenti futur discoveri
|
D039904;D035843
|
T062;T025
|
36,314,537
|
discoveri jnj potent select coval inhibitor bruton tyrosin kinas bruton tyrosin kinas btk tec famili kinas play essenti role b cell receptor bcr signal well fc receptor signal leukocyt pharmacolog inhibit btk shown effect treat hematolog malign hypothes provid effect strategi treatment autoimmun diseas rheumatoid arthriti system lupus erythematosus report discoveri preclin properti jnj coval irrevers btk inhibitor potent whole blood activ except kinom select jnj demonstr excel oral efficaci cancer autoimmun model sustain vivo target coverag amen daili dose advanc human clinic studi investig safeti pharmacokinet
|
D001172;D001327;D008180
|
T047
|
36,314,518
|
psychoanalyt mystic interpret word explicit implicit psychoanalyt assumpt concern analyt cure includ old insightinterpret versus relationexperi dualiti synthesi two stanc ground recognit long deni yet central mystic facet psychoanalysi crucial role word talk cure psychoanalysi still recogn two aspect psychoanalysi mystic communic psychic overlap interpret word deepli interdepend analyt interpret emerg depth mystic experi psychic uniti well separ result also creat patient therapist caesura word shape contour close separ matrix psychoanalysi depend moreov moment insight psychic realiti shown often depend cross threshold nonverb toward conscious languag constant movement verbal nonverb illustr clinic vignett stress interplay mystic symbol interpret intuit
|
D011572;D011575
|
T061;T091
|
36,314,514
|
power stori stori hold import role theori practic psychoanalysi power deriv part fact human biolog program storytel stori foster connect other social ident format integr psychoanalyt theori therapeut action tell therapeut psychoanalyt theoret paradigm consid stori well posit outcom analyt treatment individu emerg open end stori encompass past present futur final autobiograph exampl demonstr share stori consolid group ident uphold perpetu group power other perpetu racial ethnic stereotyp
|
D011574;D011572
|
T061;T055;T170;T091
|
36,314,506
|
possibl chiral recognit adsorpt enantiomorph crystal impact crystal surfac polar chiral crystal remain one probabl sourc first minut chiral symmetri break trigger potenti caus yet unknown type asymmetr autocatalysi format chiral biopolym condit archean earth therefor studi adsorpt process surfac crystal may help improv understand natur initi chiral shift adsorpt activ non porous crystal respect major organ molecul essenti depend abil crystal surfac engag specif intermolecular interact work enantioselect provid hippur acid phloroglucinol crystal obtain viedma ripen condit studi adsorpt menthol enantiom solut adsorpt limonen pinen enantiom vapor establish reliabl chiral recognit experiment adsorpt isotherm chiral crystal compar isotherm achir racem mixtur crystal obtain similar condit data obtain confirm use cd spectra xrd pattern sem imag test use assess statist signific differ adsorpt adsorpt isotherm vapor differ temperatur isoster heat adsorpt differenti entropi adsorpt calcul determin chiral recognit abil depend differ enantiom thermodynam function adsorpt also isoster heat adsorpt low coverag heat liquefact ratio intermolecular interact enantiom surfac weak enantiom layer format becom difficult reduc enantioselect even make chiral recognit imposs physicochem regular reveal present work made possibl formul requir enantiomorph crystal must meet satisfactori chiral recognit molecul differ polar
|
D000327
|
T070
|
36,314,505
|
nir respons sandwich drug load system tumor target multipl combin treatment novel drug load system au si nn si sio construct layer layer assembl approach core au nanorod serv matrix near infrar light nir respons phototherm featur meanwhil assembl middl shell compos azobenzen link silica produc free radic break nn bond high temperatur brought nir irradi caus phototherm effect trigger load drug releas outer shell form sio order prevent leakag drug middl layer fulli drug load nanocarri au si nn si sio dox exhibit excel phototherm effect concentr g ml nm nir laser w cm antitumor perform au si nn si sio dox investig use human colon cancer cell hct model combin nir trigger drug releas free radic generat phototherm effect propos au si nn si sio dox exhibit improv antitumor effici use dosag g ml cell viabil achiev hct cell per well min nir laser irradi nm w cm result demonstr au si nn si sio dox exhibit wonder dosag depend antitumor perform great potenti therapeut agent tumor even use clinic
|
D006979;D009369
|
T061;T191
|
36,314,499
|
left atrial strain risk atrial arrhythmia extend ambulatori cardiac monitor mesa background abnorm left atrial la function often occur la structur chang clinic identifi atrial fibril af littl known relationship la strain risk subclin atrial arrhythmia detect extend ambulatori cardiac monitor method result total particip mesa multi ethnic studi atherosclerosi complet speckl track echocardiographi cardiac monitor mean age year particip af echocardiographi entir cardiac monitor period exclud absolut valu la reservoir booster pump conduit strain measur evalu associ la strain monitor detect af prematur atrial contract supraventricular tachycardia primari analys adjust demograph variabl blood pressur diabet smoke clinic cardiovascular diseas cardiac monitor median day detect af sd lower wors la booster pump strain associ higher risk monitor detect af ci higher prematur atrial contract frequenc ci higher supraventricular tachycardia frequenc ci addit adjust nt probnp n termin pro b type natriuret peptid la volum index tissu doppler peak veloc left ventricular eject fraction global longitudin strain littl impact associ find similar la reservoir strain null la conduit strain conclus multiethn communiti base cohort impair la strain import correl subclin atrial arrhythmia even adjust convent measur la structur function
|
D016277;D001281
|
T047;T046;T042
|
36,314,497
|
progress chronic kidney diseas risk categori risk cardiovascular diseas total mortal coronari arteri risk develop young adult cohort background previous studi worsen chronic kidney diseas ckd base declin estim glomerular filtrat rate egfr increas urin albumin creatinin ratio uacr limit later middl age older adult examin associ ckd progress incid cardiovascular diseas cvd mortal younger adult method result studi adult cardia coronari arteri risk develop young adult initi age year prospect year five year transit probabl across ckd risk categori base egfr uacr measur exam proport hazard model predict incid cvd caus mortal time vari ckd risk categori adjust demograph cvd risk factor progress ckd risk categori year occur particip driven increas uacr includ n egfr mlmin per uacr mgg compar egfr uacr demograph smoke adjust hazard ratio cvd ci low ckd risk egfr uacr ci high ckd risk egfr egfr uacr egfr uacr correspond hazard ratio caus mortal ci ci although cvd associ attenu adjust mediat cvd risk factor caus mortal associ remain statist signific conclus among young middl age adult progress higher ckd risk categori common routin monitor egfr uacr hold promis prevent cvd total mortal
|
D002318;D051436
|
T047
|
36,314,496
|
myotubularin relat protein prevent neointima format vascular smooth muscl cell prolifer inhibit polo like kinas background restenosi one main bottleneck restrict develop cardiovascular intervent therapi new signal molecul involv progress continu discov howev specif molecular mechan remain unclear mtmr myotubularin relat protein novel phosphoinositid phosphatas varieti biolog function involv divers biolog process howev role mtmr vascular biolog remain unclear herein address role mtmr neointima format vascular smooth muscl cell vsmc prolifer vessel injuri method result vessel injuri model establish use smc specif condit mtmr knockout transgen mice neointima format assess histopatholog method vsmc prolifer migrat assess use fluoresc ubiquitin base cell cycl indic transwel scratch wound assay neointima format express mtmr increas injuri mtmr defici acceler neointima format promot vsmc prolifer injuri wherea mtmr overexpress remark attenu process mechanist demonstr mtmr suppress activ plk polo like kinas interact lead inhibit activ mekerkakt mitogen activ protein kinas kinaseextracellular signal regul kinaseprotein kinas b therebi inhibit prolifer vsmc medial intima thus prevent neointima format conclus mtmr prevent neointima format vsmc prolifer inhibit plk find reveal mtmr serv inhibitor vsmc prolifer establish link mtmr plk regul vsmc prolifer mtmr may becom novel potenti therapeut target treatment restenosi
|
D010744;D057772;D017346
|
T126;T116;T037
|
36,314,495
|
childhood maltreat arteri stiff among midlif women background childhood maltreat associ arteri stiff relationship examin specif among women midlif time increas arteri stiff women studi test whether childhood maltreat associ arteri stiff among cohort midlif women method result total nonsmok perimenopaus postmenopaus women free clinic cardiovascular diseas mean age year white race black race asianpacif island mix race complet child trauma questionnair baselin follow visit year later blood pressur carotid femor puls wave veloc measur arteri stiff assess relationship childhood maltreat carotid femor puls wave veloc test linear regress model adjust time visit age race ethnic educ bodi mass index heart rate hypertens medic diastol blood pressur seventi one women sampl met criteria histori childhood maltreat women histori childhood maltreat higher carotid femor puls wave veloc b se p women without histori control time visit age race ethnic educ bodi mass index heart rate hypertens medic diastol blood pressur conclus among midlif women childhood maltreat associ arteri stiff highlight potenti long term cardiovascular implic childhood maltreat
|
D059289;D006973;D002649
|
T047;T046;T048
|
36,314,494
|
evalu speech paus alter patient acut chronic heart failur background acut heart failur frequent caus unplan hospit admiss elder patient various biomark evalu better assess status patient prevent decompens recent voic suggest cost effect noninvas way monitor diseas progress studi evalu speech paus alter patient acut decompens stabl heart failur specif aim identifi vocal biomark could use monitor patient heart failur prevent decompens method result speech paus pattern evalu patient acut patient stabl heart failur voic record perform use web browser base applic consist task speech paus pattern automat extract compar acut stabl patient clinic marker compar stabl patient paus ratio increas patient acut heart failur increas larg independ sex age eject fraction persist patient lower degre edema dyspnea furthermor paus ratio posit correl nt probnp n termin pro b type natriuret peptid control acut versus stabl heart failur collect find indic paus ratio could use identifi acut heart failur particular patient display tradit indic decompens conclus speech paus pattern alter patient acut heart failur particular identifi paus ratio easili interpret vocal biomark support monitor heart failur decompens
|
D013060;D006333
|
T047;T040;T054;T046
|
36,314,493
|
inhal carbon dioxid improv neurolog outcom downregul hippocamp autophagi apoptosi asphyxia induc cardiac arrest resuscit rat model background protract cerebr hypoperfus follow cardiac arrest ca may caus poor neurolog recoveri hypothes inhal carbon dioxid co could augment cerebr blood flow cbf improv post ca neurolog outcom method result minut asphyxia induc ca resuscit wistar rat random alloc group ngroup administ differ inhal co concentr includ control co co co co invas monitor maintain minut neurolog outcom evalu neurolog function score hour post ca minut experi cbf median interquartil rang baselin co group cbf fell interquartil rang baselin control group p cbf increas along increas inhal co concentr signific linear trend p hour post ca compar control group neurolog function score interquartil rang neurolog recoveri signific better co group neurolog function score interquartil rang p surviv differ observ brain tissu malondialdehyd p serum neuron specif enolas p level p signific lower co group tunel termin deoxynucleotidyl transferas mediat biotin deoxyuridin triphosph nick end label posit cell densiti hippocamp ca p ca p region also signific reduc co group western blot show beclin p p p lamp lysosom associ membran protein p express level lcb ii lcb ratio p signific lower co group conclus administ inhal co augment post ca cbf mitig oxid brain injuri amelior neuron injuri downregul apoptosi autophagi therebi improv neurolog outcom
|
D006323;D016887
|
T061;T047;T046
|
36,314,489
|
dynam chang cardiovascular health metric long term risk sudden cardiac death aric studi background chang cardiovascular health cvh status associ risk cardiovascular diseas howev studi explor chang pattern cvh relat risk sudden cardiac death scd aim examin link baselin cvh chang cvh time risk scd method result analys conduct prospect cohort aric atherosclerosi risk communiti studi start aric enrol individu year age us communiti forsyth counti north carolina jackson mississippi suburb minneapoli minnesota washington counti maryland subject ideal metric cvh categor poor intermedi ideal cvh respect chang cvh year consid primari studi outcom physician adjud scd studi popul consist subject data cvh chang median follow year case scd record strong invers associ baselin cvh metric time vari cvh metric risk scd compar subject consist poor cvh risk scd lower chang poor intermediateid hazard ratio hr ci intermedi poor hr ci intermedi ideal hr ci ideal poorintermedi cvh hr ci consist intermedi hr ci consist ideal cvh hr ci similar result also observ non scd conclus compar consist poor cvh pattern chang cvh associ lower risk scd find highlight import promot ideal cvh primordi prevent scd
|
D002318;D016757;D000082742;D006305
|
T080;T033;T081;T047;T046;T058
|
36,314,488
|
circul solubl cd associ cardiovascular outcom mortal identif genet variant older individu cardiovascular health studi background monocytesmacrophag particip cardiovascular diseas cd cluster differenti monocytemacrophag receptor shed scd solubl cd reflect monocytemacrophag activ examin associ scd incid cardiovascular diseas event perform genom wide associ studi identifi scd associ variant method result measur plasma scd adult age year women black chs cardiovascular health studi use cox regress model associ scd incid event mortal median follow year genom wide associ studi analys stratifi race adjust age sex race ethnic scd level associ caus mortal hazard ratio hr ci per sd increas cardiovascular diseas mortal hr ci incid coronari heart diseas hr ci incid heart failur hr ci adjust eg cardiovascular diseas risk factor incid coronari heart diseas lost signific european american individu genom wide associ studi identifi variant chromosom near mgat top result rs p variant near chromosom gene asgr rs p variant near chromosom gene stgal region replic european ancestri addit pro cohort longitudin cohort studi nest danish arm anglo danish dutch studi intens treatment intens treatment peopl screendetct diabet primari care black individu identifi variant chromosom rs p hla region variant rs p near chromosom gene mylk conclus monocyt function measur scd may predict overal cardiovascular specif mortal incid heart failur
|
D002318;D006333;D015703
|
T129;T047;T046
|
36,314,475
|
explor fluoresc enhanc split g quadruplex toward dna templat agnc applic ometho detect herein fluoresc enhanc split g quadruplex g toward dna templat agnc dna agnc systemat studi shown two g rich probe ratio guanin g base best split mode spacer length zero base two side could present optim distanc agnc split g light result split g coupl dna agnc ometho ome detect success fabric develop fluoresc aptasensor could sens ome concentr rang nm detect limit nm moreov aptasensor perform well real sampl detect
|
D012834;D053768
|
T196;T073
|
36,314,470
|
magnet reson imag reveal microemboli mediat patholog chang brain microstructur diabet rat relev vascular cognit impairmentdementia diabet doubl risk vascular cognit impair under reason remain unclear present studi determin tempor spatial chang brain structur microemboli inject use diffus mri dmri control diabet rat receiv cholesterol crystal inject cognit test follow week dmri scan perform baselin week post novel object recognit test lower recognit index along decreas spontan altern maze test diabet rat dmri show inject caus infarct two diabet anim n none control n diabet radial diffus dr increas fraction anisotropi fa decreas cortex indic loss tissu integr edema dorsal hippocampus mean diffus md axial diffus da dr signific increas indic loss axon myelin damag histolog analys confirm tissu damag microgli activ diabet rat result suggest injuri associ cerebrovascular dysfunct greater diabet may caus cognit deficit strategi improv vascular function prevent therapeut approach vascular cognit impair
|
D066127;D003921;D060825;D015140
|
T050;T024;T023;T047;T048
|
36,314,438
|
surgic correct ascend aorta aortic root aneurysm associ coarctat descend aorta case report show perform simultan open surgic correct aortic root aneurysm aortic stenosi interposit aortic composit graft transdiaphragmat extra anatom correct aortic coarctat
|
D001017;D017545;D019917
|
T061;T019;T047
|
36,314,412
|
size reduct skull shape parallel follow evolutionari forest savanna transit platyrrhini monkey strong physiolog behavior differ allow anim live forest versus savanna exampl terrestri forest dwell mammal tend small compar speci live savanna robust capuchin monkey genus sapajus widespread tropic south america occur forest savanna environ forest speci consid basal evolutionari context whether skull shape size variat associ variat resourc use remain unknown particular two speci live savanna sapajus libidinosus cay show savanna speci present converg size skull characterist may facilit live new environ geometr morphometr method use assess skull size shape variat sapajus specimen distribut across south america use phylogenet general least squar test size environment variabl multivari morpholog trajectoriesparti least squar analys skull shape detect shape differ specimen forest savanna biom find reveal sapajus size reduct evolutionari transit forest savanna process relat increas season moreov found morpholog parallel skull eg muzzl shorten larg molar two savanna speci featur may facilit process harder food fallback resourc associ phenotyp differ evolutionari process colon savanna primat includ earli hominin lead morpholog adapt toler stress season environ bodi size reduct ingest mastic tough food
|
D051078;D000080523
|
T015
|
36,314,407
|
bonobo social organ season forest savanna ecoton lomami nation park examin relationship food primat social organ help us understand environ shape hominin social evolut howev debat whether social differ two closest relat bonobo pan paniscus chimpanze pan troglodyt due differ food avail respect habitat nonenvironment factor promin theori bonobo communiti social cohes stabl parti center gregari femal evolv food rich habitat individu especi femal less burden competit groupmat howev research bonobo habitat season variat food need studi measur food avail bonobo social organ luzaka new site season forest fragment fruit abund dispers record year luzaka method use wamba bonobo site season stabl habitat terrestri herbac veget densiti measur luzaka bonobo parti also record year use camera trap fruit season dispers luzaka wamba howev social organ luzaka bonobo resembl social organ bonobo less season site minor effect fruit clump parti size without effect proport femal parti suggest luzaka clump fruit slight affect social cohes disproportion affect femal bonobo social cohes femal gregari appear consist compat season habitat
|
D019974;D065948
|
T015;T082
|
36,314,348
|
clinic outcom vaccin unvaccin patient covid popul base analysi real life data vaccin covid sore need popul base analysi aim investig hospit risk covid subject compar featur vaccin unvaccin patient
|
D000086382
|
T047;T067
|
36,314,347
|
first line treatment overal surviv egfr mutat posit advanc non small cell lung cancer nation cohort studi non squamous non small cell lung cancer nsclc first lead caus cancer relat death taiwan studi aim evalu effect first line target therapi advanc epiderm growth factor receptor egfr mutat posit non squamous nsclc taiwan
|
D002289;D008175
|
T191
|
36,314,346
|
role hmgb format chronic thromboembol pulmonari hypertens acut pulmonari embol acut pulmonari embol pe may common fatal condit sever countri untreat inadequ therapeut pe patient common occur long term complic affect patient surviv treatment prognosi contribut right heart diseas may even fatal date pathogenesi chronic thromboembol pulmonari hypertens cteph due acut pulmonari embol remain unclear henc immedi demand medic direct aim prevent manag progress cteph previous studi shown inflammatori respons associ thrombosi develop pulmonari cardiovascular diseas high mobil group b hmgb damag associ molecular pattern damp involv deep vein thrombosi inflammatori reaction vascular remodel thrombosi pulmonari hypertens therefor hypothes hmgb particip process cteph develop acut pe paper detail dynam chang hmgb relationship hmgb advanc cteph acut pe better understand pathogen mechan potenti clinic applic
|
D006976;D024243;D011655
|
T123;T047;T046;T116
|
36,314,345
|
preval cari first perman molar among children saudi arabia retrospect studi studi investig preval dental cari first perman molar among children age year saudi arabia
|
D003731
|
T033;T047
|
36,314,344
|
molecular analysi oxa produc k pneumonia strain isol patient cathet associ sepsi k pneumonia import caus hospit communiti acquir infect particular carbapenem resist strain k pneumonia spread global increas public health risk studi aim sequenc phylogenet analyz k pneumonia strain isol blood cultur patient intens care unit hospit
|
D007710;D018805
|
T047;T046
|
36,314,343
|
evalu qualiti reliabl content youtub video relat crimean congo hemorrhag fever product use share inform health relat field increas exponenti rate age common today social media platform big impact peopl opinion habit decis studi aim test content reliabl qualiti video cchf diseas publish youtub patient healthcar profession peopl use obtain inform
|
D003225;D006479;D061108
|
T005;T170;T047
|
36,314,342
|
search appropri cure vagin model anti fungal stewardship antimicrobi resist remain worldwid issu major clinic econom impact lead exceed mortal increas frequenc hospit great burden healthcar system vulvovagin especi due mix infect emerg condit appropri select antimicrobi therapi proper antimicrobi stewardship program asp may contribut minim resist develop review discuss appropri select treatment vulvovagin order reduc develop resist gynecolog practic narrat review base select literatur perform accord author experi medlin search use follow keyword vagin candida fungal infect antifung therapi limit appli paper select inclus narrat review accord relev topic judg author worldwid antimicrobi treatment gynecolog asp focus prescrib system expens antifung drug treatment select consid sever factor recent topic azol recommend suitabl altern oral system azol given similar efficaci limit clinic recurr particular fenticonazol alreadi propos altern system antifung drug limit onset resist optim select antimicrobi treatment help reduc develop resist gynecolog practic given wide action spectrum abil exert antimicrobi activ fungi bacteria mix infect fenticonazol may consid suitabl first line empir therapi vagin mix infect avoid alter intestin microflora minim risk select drug resist microbi strain
|
D060085;D014848;D000890
|
T121;T047
|
36,314,341
|
clinic laboratori predictor long covid children singl center retrospect studi major children experi mild cours acut coronavirus diseas covid studi look long term recoveri covid infect children purpos studi identifi predictor long covid perform thorough analysi clinic laboratori demograph characterist children covid
|
D000086382;D011024;D018352
|
T047;T067
|
36,314,340
|
prognost role albumin bilirubin grade patient advanc non small cell lung cancer treat immun checkpoint inhibitor aim explor prognost role baselin albumin bilirubin level albi efficaci immunotherapi patient advanc non small cell lung cancer nsclc
|
D002289;D008113;D008175
|
T191
|
36,314,339
|
potenti prognost novel marker piv pile score predict surviv outcom hepatocellular cancer aim investig prognost signific novel immun marker piv pile score score composit piv ldh ecog ps patient hcc singl center
|
D006528;D008113
|
T191
|
36,314,338
|
efficaci safeti pikaktmtor inhibitor combin trastuzumab therapi posit breast cancer meta analysi activ pikaktmtor pathway patient posit breast cancer associ acquir resist trastuzumab random control trial rcts meta analysi design evalu clinic efficaci safeti pikaktmtor inhibitor combin trastuzumab posit breast cancer
|
D001943;D000068878;D000074322
|
T121;T129;T191;T116
|
36,314,337
|
vitamin sensit resist human bladder cancer cell cisplatin regul sirtuin gene express cisplatin standard chemotherapeut agent advanc bladder cancer efficaci limit due drug resist vitamin may revers cancer multidrug resist potenti molecular mechan still partial known purpos studi explor mechan vitamin revers cisplatin resist bladder cancer improv therapeut efficaci amelior prognosi cisplatin resist bladder cancer
|
D001749;D000970
|
T121;T191;T109
|
36,314,336
|
side specif differ tumor bud non metastat colon cancer recent literatur suggest tumor bud tb may signific clinic impact colorect cancer studi aim reveal effect tb long term outcom patient reveal whether differ tumor locat tb colon cancer
|
D003110
|
T191
|
36,314,335
|
impact sleep status lung adenocarcinoma risk prospect cohort studi associ sleep status lung adenocarcinoma risk analyz use long term follow data patient period provid refer explor associ sleep status lung adenocarcinoma develop
|
D007319;D012893;D000077192;D008175
|
T184;T047;T191;T048
|
36,314,334
|
c reactiv protein albumin ratio predict sever coronari arteri diseas ischemia myocardi perfus scintigraphi mps prognost import demonstr myocardi ischemia syntax score ss coronari angiographi prognost import demonstr extent coronari arteri diseas cad c reactiv protein crp albumin prognost marker atherosclerosi inflamm studi aim investig relationship crpalbumin ratio car sever myocardi ischemia ss patient stabl cad
|
D003324;D017202
|
T047
|
36,314,333
|
associ coronari plaqu characterist coronari calcif bone miner densiti postmenopaus women aim investig associ postmenopaus osteoporosi differ measur locat coronari plaqu burden morpholog detect coronari comput tomographi angiographi ccta
|
D015663;D001851;D010024;D002114
|
T047;T046
|
36,314,332
|
high serum amh inhibit patholog growth low biomass endometri microbiom although host microbiom play role hormon status fertil issu yet clarifi sinc endometrium steril tissu accept microbiota grow normal condit aim studi reveal characterist endometri microbiota accord serum amh level women implant failur
|
D007246;D064307
|
T032;T033;T028;T046;T001
|
36,314,331
|
comparison immunohistochem characterist endometrioma non endometriot benign ovarian cyst aim studi investig exist neuroendocrin cell compar densiti normal ovarian tissu endometriot non endometriot benign ovarian cyst
|
D004715;D018293;D018291;D010048;D010051
|
T047;T191
|
36,314,330
|
silico analysi impact pole mutat cladribin dock polymeras exonucleas pole enzym involv dna replic may attract therapeut target various cancer sought model impact specif pole mutat protein function due lack crystal structur tertiari structur wild type four common mutant model use tasser server
|
D004257;D018269
|
T191;T126;T116
|
36,314,329
|
analysi result case genom copi number variat sequenc pregnant women prenat diagnosi studi explor use genom copi number variat sequenc cnv seq prenat diagnosi pregnant women
|
D056915;D025063
|
T045;T047;T019;T086
|
36,314,328
|
burden brain central nervous system cancer china primari central nervous system cns cancer predomin sourc mortal morbid global studi aim analyz burden variat trend cns cancer china
|
D016543
|
T191
|
36,314,327
|
long term result use fusion promot new generat interspin process devic ipd bacfus monocentr prospect studi lumbar micro instabl diffus problem most elder popul interspin process devic ipd introduc clinic practic reliev dynam compress nerv root due instabl first generat ipd achiev bone fusion good immedi postop result last long term recent new version ipd bacfus introduc aim achiev postop fusion
|
D013130;D013123
|
T061;T020
|
36,314,326
|
anti leucin rich glioma inactiv protein antibodi associ enceph complic minim chang nephrot syndrom case report aim studi summar clinic featur diagnosi treatment leucin rich glioma inactiv protein lgi antibodi associ enceph coexist minim chang nephrot syndrom mcns moreov strengthen awar diseas increas number studi describ coexist autoimmun enceph system autoimmun diseas
|
D020363;D009402;D004660;D005910
|
T047;T191
|
36,314,325
|
long term chang cerebr ocular hemodynam carotid endarterectomi symptomat patient unilater carotid arteri stenosi aim current studi describ altern pattern cerebr ocular blood flow veloc bfvs symptomat patient unilater carotid stenosi carotid endarterectomi
|
D016894;D016893
|
T061;T047;T020
|
36,314,324
|
autoimmun hepat monozygot twin case report autoimmun hepat chronic liver diseas caus dysfunct immun system wide believ autoimmun hepat accumul famili found autoimmun hepat accumul monozygot twin
|
D019693;D006111
|
T047
|
36,314,323
|
hepatoprotect effect combin l carnitin magnesium hydroxid nonalcohol fatti liver diseas patient doubl blind random control pilot studi non alcohol fatti liver diseas nafld still accept pharmacolog therapi even though monotherapi l carnitin magnesium supplement exhibit essenti benefici role nafld treatment despit new nafld treatment strategi focus combin therapi combin l carnitin magnesium yet examin nafld patient aim assess efficaci l carnitin combin magnesium nafld patient
|
D065626;D061385
|
T121;T047
|
36,314,322
|
effect procalcitonin immatur granulocyt ratio predict develop acut necrot pancreat evid case acut pancreat ap one diseas surgic clinic deal mortal rate approxim case rate may increas pancreat necrosi case therefor earli diagnosi treatment import necrot pancreat aim studi present guid effect procalcitonin immatur granulocyt ratio ig plan earli diagnosi treatment acut necrot pancreat
|
D019283
|
T047
|
36,314,321
|
cost effect analysi ad omega vitamin supplement standard therapi treat pain crise pediatr sickl cell diseas patient pain crise repres predomin complic sickl cell diseas scd approv treatment pain crise mani countri hydroxyurea plus potent analges earlier clinic trial conclud omega vitamin potenti therapeut impact pain crise howev limit research evalu therapeut applic cost effect paper aim compar cost effect omega vitamin supplement standard therapi treat pain crise among children scd
|
D000755;D015525
|
T123;T047;T121;T109
|
36,314,320
|
impact postnat nutrit neurodevelopment outcom rat model intrauterin growth restrict limit data nutrit manag infant intrauterin growth restrict iugr postnat protein supplement promot growth common clinic practic neonatolog present studi aim investig consequ protein supplement long term growth brain bodi weight brain histolog behavior outcom rat model iugr
|
D005317;D001921
|
T023;T046
|
36,314,319
|
microscop coliti forgotten condit clinic case review literatur microscop coliti uncommon chronic inflammatori diseas colon character wateri non bloodi diarrhea often forgotten misdiagnos
|
D046728
|
T047
|
36,314,318
|
antihypertens treatment calcium channel blocker renal protect focus lercanidipin lercanidipineenalapril aim studi review literatur clinic pharmacolog lercanidipin experiment clinic evid evalu abil reduc proteinuria preserv renal function use monotherapi combin angiotensin convert enzym ace inhibitor enalapril
|
D000959;D006973
|
T121;T047
|
36,314,317
|
pulmonari hypertens elder overdiagnosi distinct entiti diagnosi pulmonari hypertens ph elder becom common recent possibl overdiagnosi misdiagnosi may aris elder due accompani physiolog chang comorbid studi aim reveal clinic find individu age year older diagnos group group ph determin differ younger adult
|
D006976
|
T046
|
36,314,316
|
sever asthma long term benralizumab effect real life long term efficaci benralizumab real life clear known assess long term effect persist anti il r treatment group sever eosinophil asthmat
|
D018927;D001249
|
T121;T047
|
36,314,315
|
assess olfactori function sniffin stick bakeri worker expos flour dust studi use sniffin stick test batteri evalu olfactori function employe bakeri expos flour dust
|
D000857
|
T033;T047
|
36,314,314
|
weber gland immunehistopatholog pediatr recurr tonsil obstruct tonsillar hypertrophi case recurr tonsil obstruct tonsillar hypertrophi common childhood constitut two major caus tonsillectomi age group studi literatur immunehistopatholog chang recurr obstruct tonsillar hypertrophi weber gland studi aim histopatholog immunohistochem examin weber gland pediatr patient recurr
|
D014069;D014068
|
T061;T047
|
36,314,313
|
effect chlorhexidin salvadora persica base mouthwash reduc periodont inflamm whole salivari il level non surgic periodont therapi young light cigarett smoker aim assess effect chlorhexidin chx salvadora persica sp base mouthwash reduc periodont inflamm whole salivari interleukin il level non surgic periodont therapi young light cigarett smoker
|
D032121;D062789
|
T131;T073;T002;T109
|
36,314,312
|
preoper anemia complic total joint arthroplasti systemat review meta analysi purpos review collect data literatur assess impact preoper anemia complic total joint arthroplasti tja
|
D019644;D019645;D000740;D018805
|
T061;T047;T046
|
36,314,311
|
clinic effect open reduct intern fixat steel plate tricep approach treatment fractur middl lower humerus stabil fractur middl lower displac humer shaft poor surgeri current main treatment posterolater approach upper arm mani advantag wide use clinic applic aim studi investig clinic effect open reduct intern fixat steel plate tricep approach treatment fractur middl lower humerus
|
D006810
|
T037
|
36,314,310
|
alpha lipoic acid could promis treatment steroid induc osteonecrosi glucocorticoid induc osteonecrosi serious debilit health problem present studi investig effect alpha lipoic acid glucocorticoid induc osteonecrosi rat
|
D008063;D010020
|
T121;T127;T109;T047;T046
|
36,314,309
|
characterist vertic drop jump screen anterior cruciat ligament injuri clarifi characterist vertic drop jump vdj screen athlet high risk acl injuri compar kinemat kinet electromyograph variabl differ vdj
|
D000070598
|
T037
|
36,314,308
|
potenti cerebrovascular protect function lycium barbarum polysaccharid allevi hyperglycemia aggrav cerebr ischemiareperfus injuri hyperglycem rat lycium barbarum polysaccharid lbp effici primari compound lycium barbarum shown allevi hyperglycemia aggrav cerebr ischemiareperfus ir injuri howev cerebrovascular chang relat diabet mellitus dm potenti cerebrovascular protect effect lbp still unknown studi aim explor cerebrovascular protect function lbp cerebr ir injuri diabet rat potenti mechan
|
D003921;D002545;D015427;D006943
|
T050;T033;T037;T047;T046
|
36,314,307
|
therapeut effect shogaol acetaminophen induc hepatotox mice experiment studi acetaminophen apap one common use analges antipyret caus serious liver damag taken larg quantiti adult children also shogaol activ compound obtain ginger anti inflammatori antioxid properti studi aim examin therapeut effect shogaol apap induc hepatotox
|
D056486;D008107
|
T033;T047;T037
|
36,314,306
|
fenofibr amelior letrozol induc polycyst ovari rat via modul ppar tnfcd pathway polycyst ovari syndrom pcos preval endocrin health problem childbear period serious affect fertil femal fenofibr peroxisom prolifer activ receptor alpha ppar agonist show benefici effect model endocrin disturb thus evalu potenti therapeut effect fenofibr experiment pcos
|
D011085;D011345
|
T121;T047;T109
|
36,314,305
|
swept sourc endoscop optic coher tomographi real time imag system base gpu acceler axial megahertz high speed scan order solv problem imag real time process correct high speed endoscop swept sourc optic coher tomographi ss oct high optim comput unifi devic architectur base platform use field programm gate array summar applic experi
|
D041623;D007091
|
T060;T066
|
36,314,304
|
studi creat risk factor model predict develop keratoconus among saudi arabian popul interact hereditari environment variabl thought caus keratoconus progress ectat corneal condit identif risk factor necessari sinc current subject intens debat crucial manag prevent diseas object studi gain better understand risk factor associ onset progress keratoconus would valuabl eye care profession patient saudi arabia
|
D007640
|
T047
|
36,314,303
|
effect chronotyp sexual satisfact qualiti life coupl physiolog psycholog behavior variabl circadian regular audit human chronotyp describ individu time prefer regard mentalphys endeavor repres circadian rhythm physiolog express studi aim investig effect coupl chronotyp sexual satisfact qualiti life
|
D011788;D012725
|
T078;T055;T053;T032
|
36,314,302
|
amelior effect trigonella foenum graecum l fenugreek extract tablet exhaust exercis induc fatigu rat suppress mitophagi skelet muscl trigonella foenum graecum l fenugreek wide use leafi veget spice china north africa recent studi report fenugreek reduc fatigu howev antifatigu mechan remain unclear therefor studi aim investig potenti antifatigu effect fenugreek extract fe mitophagi under mechan
|
D029910
|
T002
|
36,314,296
|
knowledg attitud incom pharmaci student toward pharmacogenom survey reliabl aim assess knowledg attitud toward pharmacogenom pgx incom doctor pharmaci student evalu intern structur reliabl pgx survey identifi variabl associ differ respons method pgx survey base core pharmacist compet pgx creat result analyz respons believ pgx use tool relev futur practic state lack confid clinic pgx knowledg item pgx survey includ three factor show high reliabl prior geneticpgx test unsatisfactori medic experi associ posit attitud toward pgx conclus major student posit attitud toward pgx lack knowledg genet concept clinic pgx
|
D013339
|
T097
|
36,314,266
|
singl port laparoscopi versus convent laparoscopi benign adnex mass pregnanc retrospect case control studi compar oper outcom singl port laparoscopi spl convent laparoscopi cl remov adnex mass pregnanc
|
D000291;D010535
|
T060;T047;T061
|
36,314,259
|
precis fast control dissolv oxygen level tumor chip vitro cell cultur often perform unphysiolog hyperoxia sinc oxygen partial pressur convent incub set mmhg close ambient air oxygen valu higher human tissu oxygen level vivo oxygen partial pressur rang mmhg lung alveoli mmhg skin epidermi import patholog condit cancer cell experi oxygen pressur lower healthi tissu although hypox incub regul gas oxygen take account dissolv oxygen concentr cell cultur medium context organ chip micro physiolog system develop present new system call oxali oxygen aliment system allow fine control dissolv oxygen level cell cultur medium oxali regul simultan gas composit inlet reservoir pressur modul pneumat valv open dual regul allow pressur driven liquid flowrat level oxygen dissolv chip control independ oxali offer unpreced featur oxygen equilibr time lower minut accuraci mmhg perform reach chip perfus flow low l min low flow rate allow shear stress experienc cell chip accur control addit system enabl modul ph cell cultur medium modul co fine control monitor ph pave way new precis investig physiolog patholog biolog process use oxali context tumor chip demonstr capac system recapitul hypoxia induc gene express offer innov strategi futur studi role hypoxia malign progress drug resist
|
D010100;D009369
|
T123;T196;T121;T191
|
36,314,257
|
prepar nanoscal cation metal organ framework nano mn iii tp theranost base valenc chang singl treatment strategi produc signific effect cancer treatment difficult due complex variabl tumor environ herein consid express glutathion gsh tumor environ reduc mn mn mn exhibit excel weight magnet reson imag perform good fenton like effect mn base nano cation metal organ framework mof size nm synthes label nano mn iii tp show outstand weight mri perform fenton like effect due valenc chang mn ion meanwhil mtxna nano mn iii tp obtain load anion anticanc drug methotrex disodium mtxna could releas mtxna specif gsh solut differ ph valu temperatur result improv tumor suppress effect nano mn iii tp base nanoplatform effect combin magnet reson imag mri cdt chemotherapi could use potenti therapeut agent multimod therapi also expect appli clinic tumor treatment
|
D000073396;D053758;D009369;D000970
|
T121;T191;T073;T109
|
36,314,251
|
associ tp gc polymorph differ cancer type updat meta analysi case control studi tp gc variant associ elev cancer risk evid inconclus perform meta analysi clarifi role variant cancer develop
|
D020022;D015179
|
T032;T191
|
36,314,244
|
achiev target blood pressur among communiti resid hypertens factor associ therapeut failur northern territori japan studi aim determin rate achiev target blood pressur bp defin japanes hypertens manag guidelin examin factor associ achiev target bp
|
D006973;D051436
|
T047
|
36,314,159
|
archaeolog evid think possibl hominin evolut emerg abil think futur possibl must play influenti role human evolut drive rang foresight behaviour includ prepar communic technolog innov review archeolog evid behaviour indic foresight find earliest sign hominin retain tool transport materi repeat futur use emerg around onward indic technic social chang reflect advanc foresight third period start around year ago hominin appear increas reli materi cultur shape futur exchang idea possibl visibl sign storytel even entir fiction scenario appear last year although current evid suggest distinct transit evolut capac think futur warn issu taphonomi archaeolog sampl like skew pictur human cognit evolut articl part theme issu think possibl mechan ontogeni function phylogeni
|
D015186
|
T015
|
36,314,158
|
counterfactu curios motiv think might counterfactu inform inform might form content counterfactu thought emot like regret relief recent research suggest human adult children well rhesus monkey demonstr counterfactu curios motiv seek counterfactu inform make decis base contemporari theori curios inform seek broad rang empir literatur suggest multipl heterogen psycholog process contribut peopl motiv counterfactu inform includ process identifi curios literatur general potenti use counterfactu inform adapt decis make long term instrument valu drive reduc uncertainti addit suggest counterfactu inform may particular allur role causal reason relationship predict decis make potenti fulfil emot regul self serv goal futur direct suggest includ investig role individu differ counterfactu curios learn wellb articl part theme issu think possibl mechan ontogeni function phylogeni
|
D005106;D004644
|
T055;T041
|
36,314,157
|
pupillometri possibl investig infant represent altern possibl contrast possibl fundament adapt valu predict learn development research howev yield controversi find data suggest preschool might troubl plan action take account mutual exclus possibl studi reveal earli understand altern futur outcom base infant look behaviour better understand origin abil use pupil dilat potenti indic infant represent possibl ten month old engag object identif task watch video anim three differ object ident top part move behind two screen import target object emerg one screen remain partial occlus reveal top part compat vari number possibl ident adult pupil diamet grow monoton amount inform held memori expect infant pupil size would increas number altern sustain memori candid ident partial occlud object found pupil diamet increas object potenti ident month old discuss implic result foundat human capac repres altern articl part theme issu think possibl mechan ontogeni function phylogeni
|
D007858;D018730
|
T062;T055;T041;T061
|
36,314,156
|
think possibl mechan ontogeni function phylogeni human possess remark capac imagin possibl world demarc possibl imposs reason think might happen futur consid present would look like past turn differ reason caus effect weigh altern cours action regret mistak theme issu lead expert across life scienc provid ground break insight proxim question think possibl work develop ultim question adapt function evolutionari histori togeth contribut delin neurophysiolog cognit social mechan involv mental simul possibl state realiti point conceptu chang understand singular multipl possibl human develop contribut also demonstr think possibl augment learn decis make judgement highlight aspect capac appear share non human anim aspect may uniqu human throughout issu becom clear mani development mileston achiev childhood mani signific evolutionari cultur triumph human speci understood refer increas complex reason possibl articl part theme issu think possibl mechan ontogeni function phylogeni
|
D013850;D015186
|
T078;T015;T041
|
36,314,155
|
anchor present preschool accur infer futur confront past peopl often specul futur hold wonder happen tomorrow world like distant futur nonetheless peopl abil consid futur possibl may restrict consid futur adult show end histori illus believ chang past futur preschool even limit anticip futur chang year old insist current desir persist later life find suggest deficit children adult abil simul altern possibl pertain howev report four experi n suggest otherwis least children find year old accur infer futur prompt consid past rather present prefer children also succeed infer past prefer shown item current prefer show children reason past futur though abil hinder shown item anchor present find suggest children difficulti mental time travel reflect failur shift away present rather inabl simul altern possibl articl part theme issu think possibl mechan ontogeni function phylogeni
|
D002657;D004644
|
T039;T040;T041
|
36,314,154
|
moral judgement reflect default represent possibl moral judgement requir repres possibl judg someon ought someth impli actual thing thing case ought done moral judgement often made quick effortless suggest may reli default rather delib represent possibl investig possibl ask particip make differ kind moral judgement either fast slowli differ action across context found moral judgement similar one anoth particip forc quick assess moral immor action suggest common default templat moral judgement becom differenti upon reflect make moral permiss judgement quick particip like judg improb irrat imposs action permiss indic default represent permiss may reflect default represent possibl direct investig reveal close relationship default represent possibl fast judgement moral permiss find demonstr role default represent possibl moral cognit articl part theme issu think possibl mechan ontogeni function phylogeni
|
D007600;D009014
|
T078;T041
|
36,314,153
|
polar imagin partisanship influenc direct consequ counterfactu think four studi examin polit partisanship qualifi previous document regular peopl counterfactu think n democrat republican first wherea prior work find peopl general prefer think thing could better instead wors ie entertain counterfactu upward versus downward direct studi find partisan like generat endors counterfactu whichev direct best align polit view second previous research find closer someon come caus negat event blame person receiv studi find effect pronounc among partisan oppos versus support leader almost caus negat event thus partisan reason may influenc altern realiti peopl find plausibl like imagin spontan view suffici ground blame articl part theme issu think possibl mechan ontogeni function phylogeni
|
D013850;D007092
|
T078;T041
|
36,314,152
|
imagin fundament function hippocampus imagin biolog function vital human experi advanc cognit despit import remain unknown imagin realiz brain substanti research focus hippocampus brain structur tradit link memori indic fire pattern spatial tune neuron repres previous upcom path space work general interpret standard view hippocampus implement cognit abil primarili relat actual experi whether past eg recollect consolid present eg spatial map futur eg plan howev relat recent find rodent identifi robust pattern hippocamp fire correspond varieti altern actual experi mani case without overt refer past present futur given find other hippocamp contribut human imagin suggest fundament function hippocampus generat wealth hypothet experi thought view tradit account hippocamp function episod memori spatial navig understood particular applic general system imagin view also suggest hippocampus contribut wider rang cognit abil previous thought articl part theme issu think possibl mechan ontogeni function phylogeni
|
D006624;D061212
|
T026;T023;T041
|
36,314,151
|
neural differ intern extern episod counterfactu thought episod counterfactu thought ecft consist imagin altern outcom past experi common sub class ecft upward ecft involv imagin past negat experi could better either one could done someth differ intern someth circumst could differ extern although previous neuroimag research shown brain default mode network dmn support upward ecft unclear differenti recruit intern versus extern upward ecft collect function magnet reson imag data particip rememb negat autobiograph memori generat either intern extern upward ecft memori rate plausibl perceiv control difficulti ecft generat intern extern ecft engag midlin region cingul cortex central node dmn activ differenti ecft howev occur outsid dmn extern ecft engag cuneus angular gyrus precuneus wherea intern ecft engag posterior cingul precentr gyrus angular gyrus precuneus addit sensit perceiv plausibl extern ecft postcentr gyrus insula activ scale perceiv plausibl intern ecft result highlight key brain region might involv case maladapt mental simul articl part theme issu think possibl mechan ontogeni function phylogeni
|
D007092;D061212
|
T041
|
36,314,150
|
wait better possibl delay gratif corvid relationship cognit capac self control abil resist temptat wait better delay possibl import cognit skill underpin decis make plan capac exert self control link intellig human chimpanze recent cuttlefish present eurasian jay garrulus glandarius delay mainten task measur abil choos prefer outcom well abil sustain delay prior outcom jay abl wait better possibl maximum wait time vari across subject also present five cognit task assess spatial memori spatial relationship learn capac task common use measur general intellig within ecolog context individu perform correl across cognit task suggest general intellig factor under perform perform task correl signific jay capac wait better possibl studi demonstr self control intellig correl jay fact correl exist divers speci suggest self control fundament featur cognit result discuss context converg evolut articl part theme issu think possibl mechan ontogeni function phylogeni
|
D046109;D000068356;D020308
|
T055;T012
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.